Research Projects & Grants

Internal

  • Evaluating the Effectiveness and Cost of Filgrastim Biosimilar at Loma Linda University Medical Center, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
  • Impact of 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing (RDT) for Treatment of Staphylococcus aureus Bloodstream Infections in Pediatric Patients, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
  • Impact of Verigene and 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing for Treatment of Gram-negative Bloodstream Infections in Pediatric Patients (VERI-24/7 GNB PEDS), Role: Investigator, LLU Dept. of Pharmacy Practice, (11/2022) Status: Approved
  • Evaluation of the health and economic outcomes following the integration of a pharmacist managed Diabetes clinic within a primary care setting, Role: Investigator, LLU Dept. of Pharmaceutical Sciences, (02/2022) Status: Approved
  • Pharmacy students' perceived personal and professional barriers for spiritual care: a qualitative study, Role: PI, LLU Dept. of Pharmaceutical Sciences, (01/2022) Status: Approved
  • Impact of COVID-19 vaccination on COVID-19 infections among LLUH employees, Role: PI, LLU Dept. of Pharmaceutical Sciences, (02/2021) Status: Completed
  • Examining students' attitudes towards academic dishonesty in California pharmacy schools, Role: PI, LLU School of Pharmacy, (06/2017 - 06/2018) Status: Completed
  • A qualitative study of California pharmacists' attitudes toward intrageneric antiepileptic drug switching, Role: PI, LLU Dept. of Pharmaceutical Sciences, (11/2014 - 11/2015) Status: Completed
  • Impact of Ceftazidime Duration on Neonatal Clinical Outcomes Across Various Weight Categories and Gestational Age, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved
  • Impact of Diagnostic Stewardship Using Microbial Cell-Free DNA Testing on Antimicrobial Utilization in Pediatric Patients, Role: Investigator, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved